Home > Cashflow Statement > CORONA REMEDIES

CORONA REMEDIES
Cash Flow from Financing Activities

    Back to Cashflow Statement
CORONA REMEDIES is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for CORONA REMEDIES
Please provide your vote to see the results

CORONA REMEDIES Last 5 Year Cash Flow from Financing Activities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023
Cash Flow from Financing Activities ₹25 Cr₹-107 Cr₹99 Cr₹-45 Cr

What is the latest Cash Flow from Financing Activities ratio of CORONA REMEDIES ?

The latest Cash Flow from Financing Activities ratio of CORONA REMEDIES is ₹25 Cr based on Mar2026 Consolidated results.
Year Cash Flow from Financing Activities
Mar2026₹25 Cr
Mar2025₹-107 Cr
Mar2024₹99 Cr
Mar2023₹-45 Cr

How is Cash Flow from Financing Activities of CORONA REMEDIES Trending?

Years Cash Flow from Financing Activities % Change
Mar2026 ₹25 Cr
Positive
Mar2025 ₹-107 Cr
Negative
Mar2024 ₹99 Cr
Positive
Mar2023 ₹-45 Cr -

Compare Cash Flow from Financing Activities of peers of CORONA REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CORONA REMEDIES ₹13,398.5 Cr 3.1% 4% NA Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹448,316.0 Cr -1.9% -3.7% 18.9% Stock Analytics
DIVIS LABORATORIES ₹251,737.0 Cr 2.6% 11.1% 56% Stock Analytics
TORRENT PHARMACEUTICALS ₹187,594.0 Cr 0.2% 1.3% 38% Stock Analytics
CIPLA ₹110,515.0 Cr -1.5% -6.4% -12.3% Stock Analytics
DR REDDYS LABORATORIES ₹95,420.6 Cr -1% -5.1% -8.1% Stock Analytics


CORONA REMEDIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
CORONA REMEDIES

3.1%

4%

NA
SENSEX

-2.4%

-4.8%

-7.2%


You may also like the below Video Courses